Hunan Xingchen Biotechnology Co., Ltd.

The company was established in April 2008 in Lengshuitan District of Yongzhou City, Hunan Province, with a registered capital of 10 million yuan. As a "specialized, sophisticated, distinctive, and innovative" small giant enterprise in Hunan Province, a national high-tech enterprise, and a provincial-level enterprise technology center, the company's mission is "safeguarding global health" and is committed to enhancing the production capacity and quality of Artemisinin through technological innovation, contributing to the global anti-malaria cause.